These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 28395553)

  • 1. Proteomics and irritable bowel syndrome.
    Tsigaridas A; Papanikolaou IS; Vaiopoulou A; Anagnostopoulos AK; Viazis N; Karamanolis G; Karamanolis DG; Tsangaris GT; Mantzaris GJ; Gazouli M
    Expert Rev Proteomics; 2017 May; 14(5):461-468. PubMed ID: 28395553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of serum proteome signature of irritable bowel syndrome: Potential utility of the tool for early diagnosis and patient's stratification.
    Tsigaridas A; Anagnostopoulos AK; Papadopoulou A; Ioakeim S; Vaiopoulou A; Papanikolaou IS; Viazis N; Karamanolis G; Mantzaris GJ; Tsangaris GT; Gazouli M
    J Proteomics; 2018 Sep; 188():167-172. PubMed ID: 28757466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The possible role of gastrointestinal endocrine cells in the pathophysiology of irritable bowel syndrome.
    El-Salhy M; Hausken T; Gilja OH; Hatlebakk JG
    Expert Rev Gastroenterol Hepatol; 2017 Feb; 11(2):139-148. PubMed ID: 27927062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Densities of rectal peptide YY and somatostatin cells as biomarkers for the diagnosis of irritable bowel syndrome.
    El-Salhy M; Hatlebakk JG; Gilja OH; Hausken T
    Peptides; 2015 May; 67():12-9. PubMed ID: 25765365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Irritable bowel syndrome: a clinical review.
    Chey WD; Kurlander J; Eswaran S
    JAMA; 2015 Mar; 313(9):949-58. PubMed ID: 25734736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent advances in the diagnosis of irritable bowel syndrome.
    El-Salhy M
    Expert Rev Gastroenterol Hepatol; 2015; 9(9):1161-74. PubMed ID: 26162959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Current Status of Translational Research on Irritable Bowel Syndrome].
    Kwon YH; Kim HJ
    Korean J Gastroenterol; 2016 Sep; 68(3):138-42. PubMed ID: 27646582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Defining the proteomic landscape of rheumatoid arthritis: progress and prospective clinical applications.
    Lourido L; Blanco FJ; Ruiz-Romero C
    Expert Rev Proteomics; 2017 May; 14(5):431-444. PubMed ID: 28425787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patients suspected of irritable bowel syndrome--cross-sectional study exploring the sensitivity of Rome III criteria in primary care.
    Engsbro AL; Begtrup LM; Kjeldsen J; Larsen PV; de Muckadell OS; Jarbøl DE; Bytzer P
    Am J Gastroenterol; 2013 Jun; 108(6):972-80. PubMed ID: 23419383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathogenic Factors in Postinfectious Irritable Bowel Syndrome - An Update.
    Iacob T; Ţăţulescu DF; Cijevschi Prelipcean C; Dumitraşcu DL
    Rev Med Chir Soc Med Nat Iasi; 2016; 120(3):515-21. PubMed ID: 30044574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aspects of the non-pharmacological treatment of irritable bowel syndrome.
    Eriksson EM; Andrén KI; Kurlberg GK; Eriksson HT
    World J Gastroenterol; 2015 Oct; 21(40):11439-49. PubMed ID: 26523108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of the Rome III criteria for the diagnosis of irritable bowel syndrome in secondary care.
    Ford AC; Bercik P; Morgan DG; Bolino C; Pintos-Sanchez MI; Moayyedi P
    Gastroenterology; 2013 Dec; 145(6):1262-70.e1. PubMed ID: 23994201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular basis of the irritable bowel syndrome.
    Vaiopoulou A; Karamanolis G; Psaltopoulou T; Karatzias G; Gazouli M
    World J Gastroenterol; 2014 Jan; 20(2):376-83. PubMed ID: 24574707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of irritable bowel syndrome in the elderly.
    Kurniawan I; Kolopaking MS
    Acta Med Indones; 2014 Apr; 46(2):138-47. PubMed ID: 25053688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A comparison between Rome III and Rome II criteria in diagnosing irritable bowel syndrome].
    Wang AJ; Liao XH; Hu PJ; Liu SC; Xiong LS; Chen MH
    Zhonghua Nei Ke Za Zhi; 2007 Aug; 46(8):644-7. PubMed ID: 17967234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Evaluation of oro-cecal transit time in patients with irritable bowel syndrome with cereal products intolerance].
    Błońska A; Konrad P; Chojnacki J; Chojnacki C
    Pol Merkur Lekarski; 2017 Mar; 42(249):116-120. PubMed ID: 28333903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of diet in the pathogenesis and management of irritable bowel syndrome (Review).
    El-Salhy M; Ostgaard H; Gundersen D; Hatlebakk JG; Hausken T
    Int J Mol Med; 2012 May; 29(5):723-31. PubMed ID: 22366773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of abuse and mood on bowel symptoms and health-related quality of life in irritable bowel syndrome (IBS).
    Kanuri N; Cassell B; Bruce SE; White KS; Gott BM; Gyawali CP; Sayuk GS
    Neurogastroenterol Motil; 2016 Oct; 28(10):1508-17. PubMed ID: 27151081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Irritable bowel syndrome: current review on pathophysiology and diagnotic aspects.
    Abdullah M
    Acta Med Indones; 2008 Oct; 40(4):218-25. PubMed ID: 19151451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Breath Methane Excretion Is not An Accurate Marker of Colonic Methane Production in Irritable Bowel Syndrome.
    Di Stefano M; Mengoli C; Bergonzi M; Klersy C; Pagani E; Miceli E; Corazza GR
    Am J Gastroenterol; 2015 Jun; 110(6):891-8. PubMed ID: 25803403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.